1. Abraham, R., and Hendy, R. J.: Irreversible Lysosomal Damage Induced by Chloroquine in the Retinae of Pigmented and Albino Rats. Exp. Mol. Pathol.12: 185–200, 1970.
2.
2. Abraham, R., and Hendy, R. J.: Retinal Lysosomal Changes in Pigmented and Albino Rats Treated with Chloroquine. Abstract No. 65, page 53, 9th Annual Meeting, Society of Toxicology, 1970.
3.
2a. Abraham, R., and Hendy, R. J.: Effects of Chronic Treatment on Lysosomes of Rat Liver Cells. Exp. Mol. Pathol.12: 148–159, 1970.
4.
3. Abraham, R., Hendy, R., and Grasso, P.: Formation of Myeloid Bodies in Rat Liver Lysosomes After Chloroquine Administration. Exp. Mol. Pathol.9: 212–229, 1968.
5.
4. Abraham, R., Hume, M., and Smith, J. A.: Histochemical Study of Lysosomal Enzymes in the Retina of the Rat. Histochemie18: 195–201, 1969.
6.
5. Alving, A. S., Eichelberger, L., Graige, B. Jr., Jones, R. Jr., Whorton, C. M., and Pullman, T. N.: Studies on the Chronic Toxicity of Chloroquine (SN-7618). J. Clin. Invest.27: 60–65, 1948.
7. Baccino, F. M.: Lysosomal Involvement in Liver Cell Vacuolation by Hypoxia. Brit. J. Exp. Path.50: 150–152, 1969.
9.
8. Bagnall, A. W.: The Value of Chloroquine in Rheumatoid Disease. A Four-Year Study of Continuous Therapy. Can. Med. Assn. J.77: 182–194, 1957.
10.
9. Berato, J., Commandre, F., Albatro, J., and Gilly, R.: A Propos d'une Observation de Syndrome Oculo-neuro-myopathique par Intoxication à la Chloroquine. Rhumatologie21: 123–125, 1969.
11.
10. Berliner, R. W., Earle, E. P. Jr., Taggert, J. V., Zubrod, C. G., Welch, W. J., Cannon, N. J., Bauman, E., Scudder, S. T., and Shannon, J. A.: Studies of the Chemotherapy of the Human Malarias. VI. The Physiological Disposition, Antimalarial Activity, and Toxicity of Several Derivatives of 4-Aminoquinoline. J. Clin. Invest.27: Suppl. 98-107, 1948.
12. Bernstein, H. N.: Chloroquine Ocular Toxicity. In Symposium on Ocular Pharmacology and Therapeutics. C. V. Mosby Co., St. Louis, pp. 164–189, 1970.
14.
13. Bernstein, H. N., and Ginsberg, J.: The Pathology of Chloroquine Retinopathy. Arch. Ophthal.71: 238–245, 1964.
15.
14. Bernstein, H., Zvaifler, N., Rubin, M., and Mansour, A.: The Ocular Deposition of Chloroquine. Invest. Ophthal.2: 384–392, 1963.
16.
15. Calkins, L. L: Corneal Epithelial Changes Occurring During Chloroquine (Aralen) Therapy. Arch. Ophthal.60: 981–988, 1958.
17.
16. Cambiaggi, A.: Unusual Ocular Lesions in a Case of Systemic Lupus Erythematosus. Am. J. Ophthal.57: 451–453, 1957.
18.
17. Ciak, J., and Hahn, F.: Chloroquine: Mode of Action. Science151: 347–349, 1966.
19.
18. Cogan, D. G., and Kuwabara, T.: The Sphingolipidoses and the Eye. Arch. Ophthal.79: 437–452. 1968.
20.
19. Dale, A. J. D., Parkill, E. M., and Layton, D. D.: Studies in Chloroquine Retinopathy in Rabbits. JAMA.193: 241–243, 1965.
21.
20. Dame, L. R.: The Effects of Atabrine on the Human Visual System. Am. J. Ophthal.29: 1432–1434, 1946.
22.
21. Datta, A., and Basu, U.: Studies on the Action of Antimalarial Drugs on Enzyme Systems: Part II. Some Quinoline-Containing Drugs on the Enzymes of the Tricarbolic Acid Cycle. J. Sci. Indust. Res.146: 5–61, 1955.
23.
22. Davidorf, F. H.: Ocular Toxicity of Systemic Drugs. Ohio State Med. J.68: 1022–1026, 1972.
24.
23. Dubois, E. L.: Systemic Lupus Erythematosus. Recent Advances in its Diagnosis and Treatment. Ann. Intern. Med.45: 163–184, 1956.
25.
24. Eadie, M. J., and Ferrier, T. M.: Chloroquine Myopathy. J. Neurol Neurosurg. Psychiat.29: 331–337, 1966.
26.
25. Elfenbein, B. I.: Dystonie Juvenile Idiocy without Amaurosis: A New Syndrome Light-and Electron-Microscopic Observation of Cerebrum. John Hopkins Med. J.123: 205–221, 1968.
27.
26. Ellis, P. P.: Ocular Complications of Systemic Medications. Texas Med.67: 70–73, 1971.
28.
27. Ellsworth, R. J., and Zeller, R. W.: Chloroquine-(Aralen-) Induced Retinal Damage. Arch. Ophthal.66: 269–272, 1961.
29.
28. Fedorko, M.: Effect of Chloroquine on Morphology of Cytoplasmic Granules in Maturing Human Leukocytes: An Ultrastructural Study. J. Clin. Invest.46: 1932–1942, 1967.
30.
29. Fedorko, M. E.: Effect of Chloroquine on Morphology of Leukocytes and Pancreatic Exocrine Cells from the Rat. Lab. Invest.18: 27–37, 1968.
31.
30. Fedorko, M. E., Hirsch, J. G., and Cohn, Z. A.: Autophagic Vacuoles Produced In Vitro. I. Studies on Cultured Macrophages Exposed to Chloroquine. J. Cell. Biol.38: 377–391, 1968.
32.
31. François, J., De Rauck, A., Cambie, E., and De Laey, J. J.: Retinopathie Chloroquinique. Bull. Soc. Beige. Opthal.160: 581–590, 1972.
33.
32. François, J., and Maudgal, M. C.: Experimental Chloroquine Retinopathy. Ophthalmologica, Basel.148: 442–452, 1964.
34.
33. François, J., and Maudgal, M. C.: Experimental Chronic Chloroquine Intoxication. Med. Pharmac. Exp.16: 579–590, 1967.
35.
34. François, J., and Maudgal, M. C.: Experimentally Induced Chloroquine Retinopathy in Rabbits. Am. J. Ophthal.64: 886–893, 1967.
36.
35. Fuhrmann, G., and Koenig, K.: Untersuchungen über die Resorptions-und Ausscheidungs-Verhältnisse von Resortren, Resachin, und Yatren. Ztschr. Tropenmed. u. Parasitol.4: 155–161, 1953.
37.
36. Fuld, H.: Retinopathy Following Chloroquine Therapy. Lancet2: 617–618, 1959.
38.
37. Gleiser, C. A., Bay, W. W., Dukes, T. W., Brown, R. S., Read. W. K., and Pierce, K. R.: Study of Chloroquine Toxicity and a Drug-Induced Cerebrospinal Lipodystrophy in Swine. Am. J. Path.53: 27–45, 1968.
39.
38. Gleiser, C. A., Dukes, T. W., Lawwill, T., Read, W. K., Bay, W. W., and Brown, R. S.: Ocular Changes in Swine Associated with Chloroquine Toxicity. Amer. J. Ophthal.67: 399–405, 1969.
40.
39. Goldman, L., Cole, D. P., and Preston, R. H.: Chloroquine Diphosphate in Treatment of Discoid Lupus Erythematosus. JAMA.152: 1428–1429, 1953.
41.
40. Goldmann, L., and Preston, R. H.: Reactions to Chloroquine Observed During the Treatment of Various Dermatologic Disorders. Am. J. Trop. Med.6: 654–657, 1957.
42.
41. Gonasun, L. M., and Potts, A. M.: In Vitro Inhibition of Protein Synthesis in the Retinal Pigment Epithelium by Chloroquine. Invest. Ophthal.13: 107–115, 1974.
43.
42. Gregory, M. H., Rutty, D. A., and Wood, R. D.: Retinal Changes and Chloroquine. Brit. Med. J.2: 428–429, 1968.
44.
43. Gregory, M. H., Rutty, D. A., and Wood, R. D.: Differences in the Retinotoxic Action of Chloroquine and Phenothiazine Derivatives. J. Path.102: 139–150, 1970.
45.
44. Harcourt, R. B., and Dobbs, R. H.: Ultrastructure of Retina in Tay-Sach's Disease. Brit. J. Ophthal.52: 898–902, 1968.
46.
45. Hendy, R., Abraham, R., and Grasso, P.: The Effect of Chloroquine on Rat Heart Lysosomes. J. Ultrastruct. Res.29: 488–495, 1969.
47.
46. Henkind, P., Carr, R. E., and Siegel, I. M.: Early Chloroquine Retinopathy, Clinical and Functional Findings. Arch. Ophthal.71: 157–165, 1964.
48.
47. Hobbs, H. E., and Calnan, C. D.: Visual Disturbances with Antimalarial Drugs, with Particular Reference to Chloroquine Keratopathy. Arch. Derm.80: 557–563, 1959.
49.
48. Hobbs. H. E., Eadie, S. P., and Somerville, F.: Ocular Lesions after Treatment with Chloroquine. Brit. J. Ophthal.45: 284–297,1961.
50.
49. Hobbs. H. E., Sorsby, A., and Freeman, A.: Retinopathy Following Chloroquine Therapy. Lancet2: 478–480, 1959.
51.
50. Hodgkinson, J. B., and Kolb, H.: A Preliminary Study of the Effect of Chloroquine on the Rat Retina. Arch. Ophthal.84: 509–515,1970.
52.
51. Holtzman, E., Novikoff, A. B., and Villaverde, H.: Lysosomes and Gerl in Normal and Chromatolytic Neurons of the Rat Ganglion Nodosum. J. Cell Biol.33: 419–435, 1967.
53.
52. Hori, Y., Toda, K., Pathak, M. A., Clark, W. H., and Fitzpatrick, T. B.: A Fine Structure Study of the Human Epidermal Melanosome Complex and its Acid Phosphatase Activity. J. Ultrastruct. Res.25: 109–120, 1968.
54.
53. Karbe, E., and Schiefer, B.: Familial Amaurotic Idiocy in Male German Shorthair Pointers. Path, Vet.4: 223–232, 1967.
55. Kurnick, M., and Radcliffe, I.: Reaction Between DNA and Quinacrine and Other Antimalarials. J. Lab. Clin. Med.54: 669–688, 1962.
57.
56. Kuroda, K.: Detection and Distribution of Chloroquine Metabolites in Human Tissues. J. Pharmacol. Exper. Therap.137: 156–161, 1962.
58.
57. Lane, R.: The Treatment of Hepatic Amoebiasis with Chloroquine. I. Hepatic Amoebiasis. J. Trop. Med.54: 198–206, 1951.
59.
58. Lefler, C. F., Lilja, H. S., and Holbrook, D. J. Jr.: Inhibition of Aminoacylation and Polypeptide Synthesis by Chloroquine and Primaquine in Rat Liver In Vitro. Biochem. Pharmacol.22: 715–728, 1973.
60.
59. Mayer, W.: Chloroquine Retinopathy. Am. J. Ophthal.53: 769–774, 1962.
61.
60. McChesney, E. W., Bank, W. F. Jr., and Fabian, R. J.: Tissue Distribution of Chloroquine, Hydroxychloroquine, and Desethylchloroquine in the Rat. Toxicol. Appl. Pharmacol.20: 501–513, 1967.
62.
61. McChesney, E. W., Bank, W. F. Jr., and Sullivan, D. J.: Metabolism of Chloroquine and Hydroxychloroquine in Albino and Pigmented Rats. Toxicol. Appl. Pharmacol.7: 627–635, 1965.
63.
62. McChesney, E. W., and McAuliff, J. P.: Laboratory Studies of the 4-Aminoquinoline Antimalarials. I. Some Biochemical Characteristics of Chloroquine Hydroxychloroquine, and SN-7718. Antibiotics Chemother.11: 800–810, 1961.
64.
63. Meier-Ruge, W.: Experimental Investigation of Morphogenesis of Chloroquine Retinopathy. Arch. Ophthal.73: 540–544, 1965.
65.
64. Meier-Ruge, W.: Die Morphologie der Experimentellen Chlorochinretinopathie des Kaninchens. Ophthalmologica150: 127–137, 1965.
66.
65. Meier-Ruge, W., and Cerletti, A.: Experimental Pathology of Chloroquine and Phenothiazine Retinopathy. Excerpta Med. Int. Congr. Ser. No. 146: Proc. XX Int. Ophthal. Congr. 1129-1136, 1966.
67.
66. Mushinski, J., Yielding, K., and Munday, J.: A Comparison of the In Vitro Effect of Steroid Hormone and Certain Antimalarials. Arthritis Rheum.5: 118, 1962.
68.
67. Monahan, R. H., and Horns, R. C.: The Pathology of Chloroquine in the Eye. Trans. Am. Acad. Ophthal. Otolaryng.68: 40–44, 1964.
69.
68. Nelson, A. A., and Fitzhugh, O.: Chloroquine (SN-7618): Pathologic Changes Observed in Rats Which for Two Years Had Been Fed Various Proportions. Arch, Path.45: 454–462, 1948.
70. Okun, E., Gouras, P., Bernstein, H., and von Sallman, L.: Chloroquine Retinopathy. A Report of Eight Cases with ERG and Dark-Adaptation Findings. Arch. Ophthal.69: 59–71,1963.
72.
71. Pambor, R., and Pambor, M.: Augenveränderungen bei Intermittierender Chlorochintherapie und Dermatologischer Indikation. Dtsch. Gesundheitsw.25: 2091–2095, 1970.
73.
72. Parker, F. S., and Irvin, J. L.: The Interaction of Chloroquine with Nucleic Acids and Nucleoproteins. J. Biol. Chem.199: 897–909, 1952.
74.
73. Penner, R., and Somers, K.: Bilateral Macular Degeneration Associated with Chloroquine Therapy. Am. J. Ophthal.54: 381–385, 1962.
75.
74. Percival, S. P. B., and Behrman, J.: Ophthalmological Safety of Chloroquine. Brit. J. Ophthal.53: 101–109, 1969.
76.
75. Percival, S. P. B., and Meancock, I.: Chloroquine Ophthalmological Safety, and Clinical Assessment in Rheumatoid Arthritis. Brit. Med. J.3: 579–584, 1968.
77.
76. Pinckers, A.: Oorspronkelijke Stukken Oogafivijkingen door Chloroquine en Hydroxychloroquine. Ned. T. Geneesk.244: 631–636, 1970.
78.
77. Potts. A. M.: Uveal Pigment and Phenothiazine Compounds. Tr. Am. Ophthol. Soc.60: 517–652, 1962.
79.
78. Potts. A. M.: Further Studies Concerning the Accumulation of Polycyclic Compounds on Uveal Melanin. Invest. Ophthal.3: 399–404, 1964.
80.
79. Potts. A. M.: The Reaction of Uveal Pigment in Vitro with Polycyclic Compounds. Invest. Ophthalmol.3: 405–416, 1964.
81.
80. Ramsey, M. S., and Fine, B. S.: Chloroquine Toxicity in the Human Eye; Histopathologic Observations by Electron Microscopy. Am. J. Ophthal.73: 229–235, 1972.
82.
81. Read, W. K., and Bay, W. W.: Basic Cellular Lesion in Chloroquine Toxicity, Lab. Invest.24: 246–259,1971.
83.
82. Rebello, D. J. A.: Ocular Reactions to Antimalarial Drugs. Arch. Dermatol.83: 785–789, 1961.
84.
83. Reinert, H., and Rutty, D. A.: Mechanisms of Chloroquine and Phenothiazine Retinopathies. Abstract 59, p. 47, 8th Annual Meeting, Society of Toxicology, 1969.
85.
84. Richards, R. D., and Wilson, W. R.: Retinopathy Associated with Chloroquine Phosphate Therapy. Am. J. Med.32: 140–143, 1961.
86.
85. Roskoski, R. Jr., and Jaskunas, S. R.: Chloroquine and Primaquine Inhibition of Rat Liver Cell-Free Polynucleotide-Dependent Polypeptide Synthesis. Biochem. Pharmacol.21: 391–399, 1972.
87.
86. Rubin, M., Bernstein, H., and Zvaifler, N.: Studies on the Pharmacology of Chloroquine with Recommendations for Treatment of Chloroquine Retinopathy. A. M. A. Arch. Ophthol.70: 474–481, 1963.
88.
87. Rubin, M., and Slonicki, A.: A Mechanism for the Toxicity of Chloroquine. Arthritis Rheumat.9: 537, 1966,
89.
88. Samuels, S., Korey, S. R., Gonatas, J., Terry, R. D., and Weiss, M.: Studies in Tay-Sach's Disease. J. Neuropath. Exp. Neurol.22: 81–97, 1963.
90.
89. Samuels, S., Gonatas, N. K., and Weiss, M.: Formation of the Membranous Cytoplasmic Bodies. J. Neuropath. Exp. Neurol.24: 256–264, 1965.
91.
90. Shearer, R. V., and Dubois, E. L.: Ocular Changes Induced by Long-Term Hydroxychloroquine (Plaquenil) Therapy. Am. J. Ophthal.64: 245–252,1967.
92.
91. Smith, J. L: Chloroquine Macular Degeneration. Arch. Ophthal.68: 186–190,1962.
93.
92. Sternberg, T. H., and Laden, E.: Discoid Lupus Erythematosus. Bilateral Macular Degeneration due to Chloroquine. Arch. Derm.79: 116–118,1959.
94.
93. Terry, R. D., and Weiss, M.: Studies in Tay-Sach's Disease. II. Ultrastructure of the Cerebrum. J. Neuropath. Exp. Neurol.22: 18–55, 1963.
95.
94. Thompson, S. W.: Baker's Acid Hematin Test for Phospholipids with a Nuclear Red Counterstain. In Selected Histochemical and Histopathological Methods. Charles C. Thomas, Springfield, Illinois, pp. 345–347, 1966.
96.
95. Ullberg, S., Lindquist, N. G., and Sjöstrand, S. E.: Accumulation of Chorio-Retinotoxic Drugs in the Foetal Eye. Nature227: 1257–1258, 1970.
97.
95a. Volk, B. W., and Wallace, B. J.: The Liver in Lipidosis. An Electron-Microscopic and Histochemical Study. Am. J. Path.49: 203–225, 1966.
98.
96. Wallace, B. J., Volk, B. W., and Lazarus, S. S.: Fine Structural Localization of Acid Phosphatase Activity in Neurons in Tay-Sach's Disease. J. Neuropath. Exp. Neurol.23: 676–691,1964.
98. Wetterholm, D. H., and Winter, F. C: Histopathology of Chloroquine Retinal Toxicity. Arch. Ophthal.71: 82–87, 1964.
101.
99. Whisnant, J. P., Espinosa, R. E., Kierland, R. R., and Lambert, E. G.: Chloroquine Neuromyopathy. Proc. Staff Meet. Mayo Clinic.38: 501–513, 1963.
102.
100. Whittem, J. H., and Walker, D.: Neuropathy and Pseudolipidosis in Aberdeen-Angus Calves. J. Path. Bact.74: 281–288,1957.
103.
101. Wilson, W.: Retinopathy During Chloroquine Therapy. Brit. J. Ophthal.45: 756–758, 1961.
104.
102. Wright, C., and Sabine, J.: Cholinesterases of Human Erythrocytes and Plasma and Their Inhibition by Antimalarial Drugs. J. Pharma. Exp. Ther.93: 230–239, 1948.
105.
103. Yanagisawa, Y., and Takase, M.: Chloroquine Retinopathy, Societatis Ophthalmologicae Japonicae, Acta (Supplementum).75: 609–618, 1971.
106.
104. Zelter, R. W., and Deering, D.: Corneal Complications of Chloroquine (Aral en) Phosphate Therapy. JAMA.168: 2263–2264, 1958.
107.
105. Zvaifler, N. J.: Antimalarial Treatment of Rheumatoid Arthritis. Med. Clin. N. Amer.52: 759–764, 1968.